|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08189 TEDA BIOMEDICAL
Nominal 
0.219 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (13,155) | (12,821) | (6,684) | 35,988 |
| Net Cash from / (used in) Investing Activities | -- | (467) | (12,931) | (8,511) | (26,512) |
| Net Cash from / (used in) Financing Activities | -- | 12,729 | 6,169 | 28,102 | (20,191) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (893) | (19,583) | 12,907 | (10,715) |
| Cash & Cash Equivalents at beginning of period | -- | 6,856 | 26,439 | 13,532 | 24,247 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | 0 | 0 | 0 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 5,963 | 6,856 | 26,439 | 13,532 |
| Remarks: | Real time quote last updated: 18/11/2024 07:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -4,123,183 |
| %Change | -63.350% |
| EPS / (LPS) | RMB -0.002 |
| NBV Per Share (¥) | RMB 0.024 |